Vol 7, No 2 (2017)

Cover Page

Full Issue

REVIEWS

PERISTOMAL RECURRENCE OF LARYNGEAL CANCER (LITERATURE REVIEW)

Guz’ A.O., Zakharov A.S., Garev A.V.

Abstract

Treatment of recurrent laryngeal cancer remains challenging for clinicians. Peristomal reccurence is one of the severest complications of laryngeal cancer that occurs in 2–15  % of patients after laryngectomy and has a poor prognosis: the two-year survival rate is 45 % in patients with stage I and stage II recurrence (according to G.A. Sisson) and 9 % among patients with stage III and stage IV recurrence. Stomal recurrence usually occurs within 2 years after surgery. The following factors can influence that: location of the tumor in the subglottic region of the larynx, size of the primary tumor, presence of regional metastases, placement of a tracheostoma before laryngectomy, and submucosal spread of the tumor to the trachea. All these factors should be taken into account in patients» management, including prescription of adjuvant therapy and choosing a treatment strategy in patients with primary disease.

Since there are multiple factors that can influence peristomal reccurence development, the disease requires comprehensive evaluation in order to provide the most adequate treatment and to prevent stomal recurrence.

Head and Neck Tumors. 2017;7(2):92-98
pages 92-98 views

NEW OPPORTUNITIES FOR IMMUNE THERAPY IN PATIENTS WITH DISSEMINATED RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Mudunov A.M., Narimanov M.N., Safarov D.A.

Abstract

Patients with head and neck squamous cell carcinoma diagnosed with recurrent tumor or distant metastases usually have the worst prognosis. Chemotherapeutic options are very limited in these patients; there is a probability of drug resistance development. The researchers continue to search more effective and less toxic drugs. In the current article, we analyze the results of the latest randomized clinical trials devoted the assessment of novel antitumor immunotherapeutic drugs – PD-1 inhibitors – in patients with head and neck squamous cell carcinoma. This studies reveal new possibilities for the treatment of these patients.

Head and Neck Tumors. 2017;7(2):99-105
pages 99-105 views

CLINICAL GUIDELINES

DIAGNOSIS AND TREATMENT OF MALIGNANT EPITHELIAL SKIN TUMORS (PROJECT)

Abstract

Objective and status of the guidelines. These Clinical guidelines consolidate opinions of the members of the expert task group on current problems of diagnosis and treatment of skin cancer at the modern stage of Russian clinical practice. The guidelines embody experience in diagnosis and treatment of this pathology of the leading specialists of scientific research institutes and large oncological centers of the Russian Federation. The guidelines were composed considering operation of oncological dispensaries with different bed capacities and diagnostic capabilities, and therefore opinions of some members of the group can differ from the version presented below. At the same time, the proposed for discussion guidelines make no claim to fully represent all aspects of the problem and can’t replace guidelines for doctors, textbooks, and scientific papers in this field.

The main objective of the guidelines is to improve early diagnosis of malignant skin pathology, its treatment, functional and social rehabilitation of patients with this pathology.

The Guidelines are based on analysis of the current state of diagnosis and treatment of malignant skin tumors of the head and neck considering experience of the leading specialists in the field and reports presented at the task group meeting on February 17th, 2017 in Kazan.

Head and Neck Tumors. 2017;7(2):114-128
pages 114-128 views

DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS

THE SIGNIFICANCE OF THE METHOD OF ULTRASONIC RESEARCH OF A THYROID GLAND WITH CONTRAST ENHANCEMENT IN THE DIFFERENTIAL DIAGNOSIS OF FOCAL NODULAR FORMATIONS

Rakitina D.A., Belyaev A.M., Radzhabova Z.A., Kostromina E.V., Kotov M.A., Nazhmudinov R.A.

Abstract

Introduction. Currently thyroid nodules are a widespread problem in clinical oncology and head and neck cancer, malignant focal lesions constitute more than 15–20  %. Accurate diagnosis is very important and determines treatment, as well as the volume of surgical intervention.

Objective – determination of the diagnostic value of the method of contrast-enhanced ultrasound in the diagnosis of thyroid cancer. Reference materials were the results of the histological study of surgical specimens.

Method. Performed a retrospective analysis of medical records of 42 patients who underwent surgery at the surgical department of head and neck tumors on the verified thyroid cancer in the N.N. Petrov Research Institute of Oncology at the Ministry of Health of Russia. The number of female patients was 36 persons (85.5 %), the number of men was 6 people (14.5 %). The average age of patients among men was 55.5 years, women – 46 years. All patients underwent surgical treatment in the amount of extirpation of the thyroid gland – 16 patients (37.5 %), hemithyroidectomy – 26 patients (62.5 %).

Results. The sensitivity of ultrasound with contrast in the diagnosis of cancer of the thyroid gland was 94.11 %, specificity was 87.5 %, diagnostic accuracy – 92.8 %.

Conclusions. The technique of ultrasound nodules thyroid with intravenous contrast enhancement has an excellent diagnostic properties, allowing to identify and verify thyroid cancer is 8 % more accurately in comparison with standard ultrasound technique.

Head and Neck Tumors. 2017;7(2):12-15
pages 12-15 views

ANALYSIS OF A MIRNA SET (MIR-21, -181A, AND -146A) AS A METHOD OF DIFFERENTIAL DIAGNOSIS OF THYROID NODULES

Samsonov R.B., Burdakov V.S., Shtam T.A., Radzhabova Z.A., Cheburkin Y.V., Vasilyev D.A., Tsyrlina E.V., Titov S.E., Ivanov M.К., Filatov M.V., Berstein L.M., Kolesnikov N.N., Malek А.V.

Abstract

Head and Neck Tumors. 2017;7(2):16-24
pages 16-24 views

CHOOSING OPTIONS OF SURGICAL TREATMENT FOR RECCURENT OROPHARYNGEAL CANCER

Zaderenko I.A., Mudunov A.M., Alieva S.B., Ahundov A.A.

Abstract

Introduction. Cancer of the oral cavity comprises 6 % of all malignant tumors. Recurrences occur in 15–30  % of patients, 50 % have local recurrences, 25–30  % – regional. The choice of treatment depends on the location and stage of the recurrence.

Objective. To choose optimal tactics for surgical treatment in patients with recurrent cancer of the oropharyngeal region.

Materials and methods. The study included 314 patients with recurrent squamous cell carcinoma of the oropharyngeal region, who were treated at the N.N. Blokhin Russian Cancer Research Center and underwent surgical, combination, or conservative treatment.

Results. Survival in respect to the time of relapse was 35,0 ± 2.0 % for early (in the course of a year) relapses and 63,0 ± 7.1 % for late (a year after treatment and longer) relapses. Five-year survival in respect to the type of treatment for early recurrences was 34.2 ± 6 % for surgical treatment, 7.7 ± 3.5 % for combination treatment, and 17.6 ± 4.6 % for conservative approach. For late relapses, it was 62.7 ± 5.9 %, 77.8 ± 10.6 %, and 59.2 ± 8.7 %, respectively. Surgical treatment was performed in the form of removal of recurrent tumors, resection and reconstruction using local flaps, extended combined surgeries, and laser or cryodestruction.

Conclusion. The method of choice for treatment of recurrent tumors of oropharyngeal cancer is surgery in the form of an extended combined surgery with defect reconstruction using musculocutaneous flaps including the pectoralis major.

Head and Neck Tumors. 2017;7(2):25-29
pages 25-29 views

ONCOLOGICAL RESULTS OF SURGICAL TREATMENT EFFECTIVENESS OF STAGE I AND II ORAL CAVITY CANCER

Karpenko A.V., Sibgatullin R.R., Boyko A.A., Chumanikhina N.S., Kostova M.G., Nikolaeva O.M., Roman L.D.

Abstract

Head and Neck Tumors. 2017;7(2):30-36
pages 30-36 views

FEASIBILITY OF INDUCTION CHEMOTHERAPY IN THE TREATMENT OF CT2N0M0 CANCER OF THE ORAL MUCOSA

Romanov I.S., Gelfand I.M., Udintsov D.B., Akhundov A.A., Ilkaev K.D.

Abstract

Introduction. The issue of selecting treatment strategy for сT2N0M0 cancer of the oral mucosa remains relevant. Induction chemotherapy (applied in order to evaluate the possibility of organ-preserving chemoradiotherapy) is widely used in clinical practice. In this case, surgical treatment is performed only when chemotherapy (CT) is ineffective or a residual tumor is detected after chemoradiotherapy (CRT). However, many specialists recommend surgical treatment on the first stage of treatment.

Objective: evaluation of the induction chemotherapy feasibility in the treatment of T2N0M0 cancer of the oral mucosa.

Materials and methods. A total of 122 patients with primary Т2N0М0 cancer of oral mucosa without regional metastases (according to clinical examination) were included in the study.

Results. In order to determine the best treatment strategy, we have compared treatment outcomes in three groups of patients. The most favorable outcomes were observed in the group of patients receiving combined treatment according to a scheme «surgery + radiotherapy (RT)/ CRT, where the overall 5-year survival rate and the progression-free 5-year survival rate were 70.4 % and 68.5 % respectively. Survival rate in this group was significantly higher (р < 0.05) than that in the group «induction CT (ICT) ± RT ± surgery» where these parameters comprised 42.2 % and 36.2 % respectively.

Conclusion. Combined treatment with a surgery on the first stage followed by RT or CRT ensures better outcomes of the cancer of the oral mucosa than the strategies that include ICT.

Head and Neck Tumors. 2017;7(2):37-44
pages 37-44 views

LENVATINIB IN TREATMENT OF RADIOACTIVE IODINE-REFRACTORY WELL-DIFFERENTIATED THYROID CARCINOMA

Romanov I.S., Mudunov A.M., Isaev P.A., Bychkov Y.M., Dolgushin M.B., Odzharova A.A., Romanova L.F.

Abstract

Well-differentiated thyroid carcinoma (WDTC) comprises > 90 % of all cases of thyroid cancer. In 10–15 % of patients, distant metastases are detected which significantly worsen the prognosis. Radioactive iodine therapy remains the main type of treatment of this patient group, but for patients with so-called radioactive iodine-refractory WDTC the prognosis is very poor. After successful phase III  studies, several drugs from the group of multikinase inhibitors are being used in clinical practice for treatment of radioactive iodine-refractory WDTC, for example lenvatinib. In this article, we present a group of patients with radioactive iodine-refractory WDTC who received lenvatinib therapy.

Head and Neck Tumors. 2017;7(2):45-52
pages 45-52 views

ORIGINAL REPORTS

STATIC CORRECTION OF THE FACE DUE TO FACIAL NERVE DAMAGE IN TREATMENT OF HEAD AND NECK TUMORS

Polyakov A.P., Reshetov I.V., Ratushniy M.V., Matorin O.V., Filushin M.M., Rebrikova I.V., Mordovskiy А.V., Kutsenko I.I., Nikiforovich P.A., Sugaipov A.L., Pugaev D.M.

Abstract

Introduction. Facial nerve paralysis disconnects person»s emotions and expression, causes lagophthalmos, disorders of taste, touch, salivation, and lymph efflux in the damaged area. Among causes of consistent facial nerve conduction defects, the most common is iatrogenic injury during extensive surgical interventions for removal of tumors of the parotid gland. Various surgery interventions are used for correction of such disorders. The article objective is to present results of performed static plastic surgeries using polypropylene thread in patients with facial nerve damage caused by radical parotidectomy.

Materials and methods. From 2014 to 2016 in the Department of Microsurgery of the P.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center, 14 patients underwent static correction using polypropylene thread to treat iatrogenic injury of the facial nerve after radical surgery for malignant and benign tumors.

Results. In all patients, optimal results of repair of the esthetic component of the facial nerve were achieved. Postoperative period didn»t exceed 3 days. Effect duration is longer than 3 years.

Conclusions. Use of polypropylene thread in static plastic surgery allows to perform cosmetic facial correction, eliminate gravitational ptosis and lymphostasis in patients with consistent syndrome of complete damage of facial nerve conductance.

Head and Neck Tumors. 2017;7(2):53-59
pages 53-59 views

EXPERIENCE OF USING ALLOGENIC BIOIMPLANTS IN LARYNGEAL RESECTION

Novozhilova E.N., Fedotov A.P., Chumakov I.F., Volova L.T., Olshanskaya O.V., Akhtyrskaya E.G., Kochetkova T.A., Kakorin A.

Abstract

Introduction. Currently, a great importance is being attached to improvement of the surgical component of combination treatment of locally advanced laryngeal cancer. New technological capabilities (transoral microsurgery of the larynx and robotic surgery) offer great opportunities for early cancer stages. However, in some cases capabilities of endoscopic laser intervention are limited. Therefore, open laryngeal resection is still relevant as it serves as the only type of radical organ preservation treatment for stages Т2–Т3. But major laryngeal resection is associated with a problem of tissue defect closure.

The article describes data on the use of biocompatible materials, their advantages and disadvantages. The study objective is to present experience of using a Russian allogenic bioimplant for plastic reconstruction of the opening of the larynx after laryngeal resection.

Materials and methods. The authors present their experience of using a Russian bioimplant produced in collaboration with the Samara Tissue Bank of the Research Institute of Experimental Medicine and Biotechnology of the Samara State Medical University. The material was tested in anterolateral laryngeal resection with simultaneous reconstruction in 5 patients with stages Т2–Т3 laryngeal cancer and in a patient with chondrosarcoma.

Conclusion. The Russian biocompatible implant served as a reliable, simple, cheap, and effective variant of plastic material for reconstruction of the larynx.

Head and Neck Tumors. 2017;7(2):60-64
pages 60-64 views

FAST TRACK REHABILITATION IN THYROID INTERVENTIONS

Lyadov V.K., Pashaeva D.R., Nekludova M.V.

Abstract

Introduction. Thyroid surgeries are one of the most common surgical interventions. Duration of hospital stay depends on the risk of postoperative complications, primarily, transient or permanent hypocalcemia, recurrent laryngeal nerve paralysis, bleeding.

Objective: presentation of first-hand results of using a protocol of enhanced recovery after thyroid surgery by us.

Materials and Methods. In the study, results of treatment of 162 patients who underwent surgery in the period from January 2014 to January 2016 are analyzed. In 22 (13.5 %) patients the surgery was performed endoscopically using bilateral axillo-breast approach (ВАВА). Results. No deaths were registered. In 2 patients, intraoperative complications were observed: In one case the recurrent laryngeal nerve was transected in a patient with retrosternal giant (larger than 15 cm) nodular goiter; in the 2nd case, the cricoid cartilage of a female patient was damaged by a harmonic scalpel during endoscopic intervention. Mean surgery duration in the studied group was 69.5 ± 15.7 min. Postoperative complications were observed in 5 (3 %) patients: In 1 it was subcutaneous emphysema after endoscopic surgery, in 2 patients – laryngospasm, in another two – transient hypocalcemia. Mean duration of hospital stay was 2.1 ± 0.5 days.

Conclusions. Based on literature data analysis and results of our study, we can conclude that the use of enhanced recovery protocols after thyroid surgeries is safe with low rate of complications and earlier hospital discharge.

Head and Neck Tumors. 2017;7(2):65-69
pages 65-69 views

ARTERIAL HYPERTENSION DURING THERAPY OF ONCOLOGICAL DISEASES WITH ANGIOGENESIS INHIBITORS: SERIOUS IMPEDIMENT OR CONTROLLED REACTION?

Kobalava Z.D., Shavarova E.K.

Abstract

Vascular endothelial growth factor signaling pathway (VSP) inhibitors are drugs for which arterial hypertension (AH) is a class effect, occurring with a frequency of up to 73 % of treated patients. Blockade of vascular endothelial growth factor or its receptor is accompanied by inhibition of the synthesis of nitric oxide, which is considered a major pathogenic mechanism for the development of AH. VSP-inhibitors therapy will be as safe as possible, if the patient prior to treatment will take a minimum assessment, allowing to identify the category of patients with high/very high cardiovascular risk. Risk evaluation is necessary not to abandon an effective therapy of VSP-inhibitors, and to provide a systematic approach to reduce the likelihood of potential cardiovascular toxicity. Blood pressure during VSP-inhibitors therapy is characterized by a rapid rise after the first dose of target therapy, as a rule, in the first cycle of treatment, ranging from no increase to double the systolic blood pressure. Usually iatrogenic AH spontaneously resolves after stopping chemotherapy. Timely prescribed antihypertensive therapy help to avoids dose reduction or interruption of the course of VSP-inhibitors, which significantly improves the survival of patients.

Head and Neck Tumors. 2017;7(2):70-80
pages 70-80 views

TUMOR MARKERS AND HEAT SHOCK PROTEINS OF CHRONIC HYPERPIASTIC LARYNGITIS AS A LIKELY PREDICTOR OF MALIGNISATION IN LARYNX EPITHELIOCYTES

Nazmudinov I.I., Saidov M.Z.

Abstract

Objective: in paper direct results of investigation the products of tumor makers – CEA (carcino-embryonic antigen), CYFRA 21-1 and SCC and heat shock proteins hsp27, hsp70, hsp90. reflacting the possibility of malignization epithelial cells in chronic hyperpiastic laryngitis.

Materials and methods. There were investigated 36 patients with chronic hyperplastic laryngitis. It was investigated the production of CEA (carcino-embryonic antigen), CYFRA 21-1, SCC and heat shock proteins hsp27, hsp70 in immune-enzyme method. The variation of serum concentration oncomarkers was investigated in dependent on the maximum production of heat shock proteins reflactihg the value of cell stress in chronic hyperplastic laryngitis. Statistics analysis was convey in programs Statistica (version 6,0) and “Biostat 4.03”.

Results. It was shown more prognostic informative in chronic hyperplastic laryngitis the level of CEA, CYFRA 21-1 and SCC on the background of maximum production of heat shock proteins hsp27, hsp70, hsp90. The serum level of CEA was higher in comparison with control. On the maximum of production hsp27, hsp70, hsp90 the concentration of CEA was 2–3 ng/ml, Cyfra 21-1 – 0–1,2 ng/ml and SCC 1–2 ng/ml. Conclusions. Variation of serum oncomarkers level of CEA – 2–3 ng/ml, CYFRA 21-1 – 0–1,2  ng/ml and SCC – 1–2 ng/ml are the prognostic value in the possibility of malignization epithelial cells in chronic hyperpiastic laryngitis. This results is important in clinical practice.

Head and Neck Tumors. 2017;7(2):81-91
pages 81-91 views

CLINICAL CASES

THE FIRST EXPERIENCE OF TRANSORAL ROBOT-ASSISTED SURGERY IN A PATIENT WITH OROPHARYNGEAL CANCER (CLINICAL OBSERVATION)

Kropotov M.A., Mosin S.V., Petrova A.L., Chernikova E.N.

Abstract

Multiple approaches are currently available for treatment of oropharyngeal cancer. Particular attention is usually paid to preservation of the normal shape of the organ and maintenance of the quality of life in patients. Early-stage oropharyngeal cancer can be treated by both radiotherapy and surgery, including transoral laser microsurgery and robot-assisted surgery.

Early diagnosis and the use of modern technological approaches allow to conduct adequate surgical treatment without significant injury of the surrounding soft tissues and bone structures, which in turn promotes both aesthetic and functional rehabilitation of the patient. The case of robot-assisted surgical treatment of the oropharyngeal tumor described in this article is a good example of this rehabilitation.

Head and Neck Tumors. 2017;7(2):106-110
pages 106-110 views

RHABDOMYOMA OF THE NASOPHARYNX (CLINICAL OBSERVATION)

Mustafaev D.M.

Abstract

Rhabdomyoma of the nasopharynx is an extremely rare disease. Currently, there are only isolated cases of rhabdomyoma of the nasopharynx described in literature. Information on the clinical picture and course of the disease is very poor. The author presents his own clinical observation of a rare localization of rhabdomyoma in the nasopharynx. Analysis of literature data and clinical observation allowed the author to conclude that rhabdomyoma of the nasopharynx has a relatively favorable prognosis given early detection, benign quality of the disease, and availability of radical surgery.

Head and Neck Tumors. 2017;7(2):111-113
pages 111-113 views

JUBILEE

ПОЗДРАВЛЯЕМ СЕРГЕЯ ОЛЕГОВИЧА ПОДВЯЗНИКОВА С ЮБИЛЕЕМ

Abstract

.
Head and Neck Tumors. 2017;7(2):129
pages 129 views